Daily News

TCTAP 2023 Daily Newspaper

TAVR Techniques in Bicuspid Anatomy - Valve Selection, Sizing, and Positioning

NEW TAVR

Daewoong Pharmaceutical Co., LTD.

Contemporary Trends in Aortic Stenosis Management - Legend's Perspective

Opening of TCTAP 2023 & Keynote Lectures

Catheter-Based Strategies to Treat Tricuspid Valve Disease

Mitral & Tricuspid Valve Therapy

Organon Korea

Insight from All Data of Left Main Revascularization (MAINCOMPARE, SYNTAX, PRECOMBAT, NOBLE, EXCEL)

Left Main & Multi-Vessel (Concept Changes After ISCHEMIA)

P2Y12 Inhibitor or Asprin for Long-term Antiplatelet Management

All About New Data of Antithrombotics

Yuhan Corporation

State-of-the-Art Technique for Transcatheter Closure of Paravalvular Leaks

Mitral & Tricuspid Valve Intervention

Radiation Management for Complex Percutaneous Coronary Intervention

Complex PCI - Calcification, Very Long Lesion

GE Healthcare AS

Great Debate on MVD 2023: Medical Therapy is Enough vs. Surgery is Still Standard

Left Main & Multi-Vessel (Concept Changes After ISCHEMIA)

The 20th Anniversary of TAVR Ceremony - From Concept to Human Application

Game of Thrones, TAVR vs. SAVR

Chong Kun Dang

10-Year Extended Follow-up of BEST Trial

Late-Breaking Clinical Trials 2023 in Asia-Pacific

Routine Functional Testing or Standard Care in High-Risk Patients after PCI

[Published in NEJM] Late-Breaking Clinical Trials 2023 in Asia-Pacific

Mitsubishi Tanabe Pharma Korea

PREVENT Trial

Future Perspective on Ongoing Trials from AMC

OCTIVUS Trial

Future Perspective on Ongoing Trials from AMC

Novartis Korea

30 Years History of FFR: From the Concept to Current Status - Legend's Perspective

Opening of TCTAP 2023 & Key Note Lectures

Upfront 2-Stent; New Concept in LM Bifurcation PCI

All Bifurcation PCI

Guerbet Korea Ltd.

How Can We Improve Reperfussion Therapy in AMI

Acute Coronary Syndrome

Left Main Revascularization; Consensus and Gaps in 2023

LM & Multi-Vessel Diseases and Bifurcation & CTO After ISCHEMIA Study